tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Nls Pharmaceutics Ltd (NLSP)
:NLSP
US Market
NLSP
NLS Pharmaceutics
RESEARCH TOOLSreports
Advertisement

NLS Pharmaceutics (NLSP) Price & Analysis

Compare
306 Followers

NLSP Stock Chart & Stats

$1.65
$0.41(19.90%)
At close: 4:00 PM EST
$1.65
$0.41(19.90%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume16.20M
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$3.07M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.11
Price to Sales (P/S)0.00
P/FCF Ratio-0.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A

NLS Pharmaceutics News

NLS Pharmaceutics AG trading halted, news pending
NLS Pharmaceutics AG trading halted, news pending
19:50 EDT NLS Pharmaceutics (NLSP) AG trading halted, news pending Published first on TheFly – the ultimate source...
11d ago
NLSP
NLS Pharmaceutics announces 1-for-10 reverse share split
NLS Pharmaceutics announces 1-for-10 reverse share split
NLS Pharmaceutics (NLSP) announced that it intends to effect a reverse share split of the company’s issued and...
12d ago
NLSP
NLS Pharmaceutics partner Kadimastem to collaborate with TargetGene
NLS Pharmaceutics partner Kadimastem to collaborate with TargetGene
NLS Pharmaceutics (NLSP) and Kadimastem, a clinical-stage biotechnology company developing breakthrough cell therapy solutions for severe diseases such...
14d ago
NLSP
NLS Pharmaceutics receives Nasdaq approval for listing
NLS Pharmaceutics receives Nasdaq approval for listing
NLS Pharmaceutics (NLSP) and Kadimastem announced an update regarding the proposed merger. On October 21, NLS received an...
18d ago
NLSP
NLS Pharmaceutics and Kadimastem Complete Merger to Form NewcelX
NLS Pharmaceutics and Kadimastem Complete Merger to Form NewcelX
The latest update is out from NLS Pharmaceutics ( ($NLSP) ). On October 30, 2025, NLS Pharmaceutics Ltd....
11d ago
6K
NLSP
NLS Pharmaceutics Expands CNS Pipeline with AEX-6xx Series
NLS Pharmaceutics Expands CNS Pipeline with AEX-6xx Series
NLS Pharmaceutics ( ($NLSP) ) has shared an announcement. On October 30, 2025, NLS Pharmaceutics announced the expansion...
11d ago
6K
NLSP
NLS Pharmaceutics and Kadimastem Continue ITOL-102 Diabetes Program Post-Merger
NLS Pharmaceutics and Kadimastem Continue ITOL-102 Diabetes Program Post-Merger
NLS Pharmaceutics ( ($NLSP) ) has shared an update. On October 29, 2025, NLS Pharmaceutics Ltd. and Kadimastem...
12d ago
6K
NLSP
NLS Pharmaceutics Announces Reverse Share Split and Name Change Amid Merger
NLS Pharmaceutics Announces Reverse Share Split and Name Change Amid Merger
NLS Pharmaceutics ( ($NLSP) ) just unveiled an update. On November 4, 2024, NLS Pharmaceutics Ltd. entered into...
12d ago
6K
NLSP
NLS Pharmaceutics and Kadimastem Finalize Merger Conditions
NLS Pharmaceutics and Kadimastem Finalize Merger Conditions
NLS Pharmaceutics ( ($NLSP) ) just unveiled an announcement. On October 28, 2025, NLS Pharmaceutics and Kadimastem announced...
13d ago
6K
NLSP
NLS Pharmaceutics Announces Strategic Collaboration for Gene-Edited Cell Therapies
NLS Pharmaceutics Announces Strategic Collaboration for Gene-Edited Cell Therapies
NLS Pharmaceutics ( ($NLSP) ) has provided an update. On October 27, 2025, NLS Pharmaceutics Ltd. announced a...
14d ago
6K
NLSP
NLS Pharmaceutics and Kadimastem Secure Nasdaq Approval for Merger
NLS Pharmaceutics and Kadimastem Secure Nasdaq Approval for Merger
NLS Pharmaceutics ( ($NLSP) ) has issued an update. On October 23, 2025, NLS Pharmaceutics Ltd. and Kadimastem...
18d ago
6K
NLSP
NLS Pharmaceutics Announces Strategic Merger with Kadimastem
NLS Pharmaceutics Announces Strategic Merger with Kadimastem
NLS Pharmaceutics ( ($NLSP) ) has provided an announcement. On November 4, 2024, NLS Pharmaceutics Ltd. entered into...
1M ago
6K
NLSP
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem
An update from NLS Pharmaceutics ( ($NLSP) ) is now available. On September 30, 2025, NLS Pharmaceutics announced...
1M ago
6K
NLSP
Closing Bell Movers: Oracle ticks higher as Trump rescues TikTok in US
Closing Bell Movers: Oracle ticks higher as Trump rescues TikTok in US
In the opening hour of the evening session, U.S. equity futures are trading flat, though sentiment has turned...
2M ago
CNXC

NLSP FAQ

What was Nls Pharmaceutics Ltd’s price range in the past 12 months?
Currently, no data Available
What is Nls Pharmaceutics Ltd’s market cap?
Currently, no data Available
When is Nls Pharmaceutics Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nls Pharmaceutics Ltd’s earnings last quarter?
Currently, no data Available
Is Nls Pharmaceutics Ltd overvalued?
According to Wall Street analysts Nls Pharmaceutics Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Nls Pharmaceutics Ltd pay dividends?
    Nls Pharmaceutics Ltd does not currently pay dividends.
    What is Nls Pharmaceutics Ltd’s EPS estimate?
    Nls Pharmaceutics Ltd’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Nls Pharmaceutics Ltd have?
    Currently, no data Available
    What happened to Nls Pharmaceutics Ltd’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Nls Pharmaceutics Ltd?
    Currently, no hedge funds are holding shares in NLSP

    Technical Analysis

    Overall Consensus
    Sell
    6Bullish
    1Neutral
    15Bearish
    Bullish
    Neutral
    Bearish
    Overall Consensus
    6
    1
    15
    Technical Analysis
    6
    1
    3
    Moving Averages
    0
    0
    12
    Technical Analysis >
    Similar Stocks
    Company
    Price & Change
    Follow
    OGEN
    Oragenics
    ―
    ―
    KALA
    Kala Pharmaceuticals
    ―
    ―
    PTIX
    Protagenic Therapeutics
    ―
    ―
    KTTA
    Pasithea Therapeutics Corp
    ―
    ―
    ONCO
    Onconetix
    ―
    ―
    Compare NLSP Stocks >

    Ownership Overview

    <0.01%3.38%96.62%
    ―
    Insiders
    <0.01% Mutual Funds
    3.38% Other Institutional Investors
    96.62% Public Companies and
    Individual Investors
    Detailed Ownership Overview >

    Options Prices

    Currently, No data available
    ---
    Popular Stocks

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing